secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K/A
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-021942
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience acquires Wisconsin Fertility Institute for $10 million in installment deal
--------------------------------------------------------------------------------

- Purchase price of $10 million payable in four annual installments of $2.5 million each, with potential offset against certain liabilities.
- Sellers can elect to receive INVO common stock for the final three installments at fixed values of $6.25, $9.09, and $14.29 per share.
- Acquired entities WFRSA and FLOW reported combined revenue of $5.3 million (2022) and $5.7 million (2021), with net income of $1.7 million and $2.3 million respectively.
- Transaction expected to close in Q2 2023; includes a five-year non-compete and non-solicitation provisions for sellers.
- Filing includes audited combined financials for years ended Dec 2022 and 2021, and unaudited for March 2023, as well as pro forma statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223021942/0001493152-23-021942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223021942/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer